57 related articles for article (PubMed ID: 1322733)
1. Prevention of calcium overload and down-regulation of calcium channels in rat heart by SR 33557, a novel calcium entry blocker.
Chatelain P; Laruel A; Beaufort P; Meysmans L; Clinet M
Cardioscience; 1992 Jun; 3(2):117-23. PubMed ID: 1322733
[TBL] [Abstract][Full Text] [Related]
2. Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
Chatelain P; Mouton J; Feys G; Laruel A; Manning AS
Cardiovasc Res; 1995 Dec; 30(6):1038-43. PubMed ID: 8746222
[TBL] [Abstract][Full Text] [Related]
3. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
4. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
5. Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation.
Zimmer HG; Kolbeck-Ruhmkorff C; Zierhut W
Cardioscience; 1995 Mar; 6(1):47-57. PubMed ID: 7605896
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes.
Chatelain P; Beaufort P; Meysmans L; Clinet M
Mol Pharmacol; 1991 Jan; 39(1):64-71. PubMed ID: 1846221
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
Deisher TA; Narita H; Zera P; Ginsburg R; Bristow MR; Billingham ME; Fowler MB; Hoffman BB
J Pharmacol Exp Ther; 1993 Jul; 266(1):262-9. PubMed ID: 8392553
[TBL] [Abstract][Full Text] [Related]
8. Inverse regulation of calcium channels and beta-adrenergic receptors in virus-transformed human embryonal cells.
Drímal J; Magna D; Knézl V; Tokárová J; Drímalová L
Gen Physiol Biophys; 1991 Apr; 10(2):125-35. PubMed ID: 1713871
[TBL] [Abstract][Full Text] [Related]
9. Myocyte response to stimulation of receptors and ion channels.
Marsh JD
Toxicol Pathol; 1990; 18(4 Pt 1):454-63. PubMed ID: 1982574
[TBL] [Abstract][Full Text] [Related]
10. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes.
Yu HJ; Ma H; Green RD
Mol Pharmacol; 1993 Oct; 44(4):689-93. PubMed ID: 7694067
[TBL] [Abstract][Full Text] [Related]
11. Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites.
Sol-Rolland J; Joseph M; Rinaldi-Carmona M
J Pharmacol Exp Ther; 1991 May; 257(2):595-602. PubMed ID: 1851830
[TBL] [Abstract][Full Text] [Related]
12. Alteration in sensitivity to isoproterenol and acetylcholine in the rat heart after repeated administration of isoproterenol.
Nomura Y; Kajiyama H; Segawa T
J Pharmacol Exp Ther; 1982 Feb; 220(2):411-6. PubMed ID: 6276535
[TBL] [Abstract][Full Text] [Related]
13. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
Liu J; Bangalore R; Rutledge A; Triggle DJ
Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
[TBL] [Abstract][Full Text] [Related]
14. Alpha 1D L-type Ca(2+)-channel currents: inhibition by a beta-adrenergic agonist and pituitary adenylate cyclase-activating polypeptide (PACAP) in rat pinealocytes.
Chik CL; Liu QY; Li B; Klein DC; Zylka M; Kim DS; Chin H; Karpinski E; Ho AK
J Neurochem; 1997 Mar; 68(3):1078-87. PubMed ID: 9048753
[TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
Melena J; Osborne NN
Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
[TBL] [Abstract][Full Text] [Related]
16. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
Neve KA; Molinoff PB
Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
[TBL] [Abstract][Full Text] [Related]
17. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required.
Venetucci LA; Trafford AW; Eisner DA
Circ Res; 2007 Jan; 100(1):105-11. PubMed ID: 17110597
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of beta-adrenoceptors inhibits calcium-dependent potassium-channels in mouse macrophages.
Rosati C; Hannaert P; Dausse JP; Braquet P; Garay R
J Cell Physiol; 1986 Dec; 129(3):310-4. PubMed ID: 2430985
[TBL] [Abstract][Full Text] [Related]
19. Beta adrenergic receptor activation attenuates the generation of inositol phosphates in the pregnant rat myometrium. Correlation with inhibition of Ca++ influx, a cAMP-independent mechanism.
Khac LD; Arnaudeau S; Lepretre N; Mironneau J; Harbon S
J Pharmacol Exp Ther; 1996 Jan; 276(1):130-6. PubMed ID: 8558422
[TBL] [Abstract][Full Text] [Related]
20. Iron(II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum.
Kim E; Giri SN; Pessah IN
Toxicol Appl Pharmacol; 1995 Jan; 130(1):57-66. PubMed ID: 7530865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
